Sammaan Capital Ltd. announces an acquisition
TL;DR
Per the Scheme of Arrangement approved by shareholders, what is the specific allocation of assets and liabilities between Sammaan Capital and the demerged entity, and how does this restructuring impact the company's reported capital adequacy ratio?
The scheme transfers the entire NBFC undertaking from Sammaan Finserve Limited (SFL) to Sammaan Capital Limited (SCL); it does not allocate individual assets and liabilities between the two entities on a discretionary basis. SCL is the Resulting Company and SFL the Demerged Company. Shareholders approved the scheme with 99.97% support on 10 September 2026. [1]
Allocation under the Scheme
- Assets transferred to SCL: All properties and assets forming part of SFL’s NBFC Business, whether recorded or unrecorded, including related rights, title documents, tangible and intangible assets, present and future assets, and contingent assets. [2]
- Operating liabilities transferred to SCL: All liabilities relating to the Demerged Undertaking as of the Appointed Date. [2]
- General or multipurpose borrowings: These are allocated to SCL in proportion to the value of assets transferred relative to SFL’s total assets immediately before the Appointed Date. [2]
- Accounting basis: The transferred assets and liabilities move at the values appearing in SFL’s books immediately before the demerger. [2]
- Assets retained by SFL: Assets belonging to SFL’s Remaining Business Undertaking remain with SFL. Encumbrances associated with transferred liabilities move to SCL’s assets unless the relevant lender or trustee agrees otherwise. [2]
Capital adequacy impact
The restructuring is intended to consolidate the NBFC business and create a broader capital and asset base, but the shareholder-meeting disclosure does not quantify a post-demerger capital adequacy ratio or a specific improvement attributable to the scheme. [3]
The reported reference points are:
- Management stated that SCL was starting with a capital adequacy ratio of 20.2% and that it would be approximately 29% pro forma for warrants. The latter is a warrant-related pro forma figure, not a quantified effect of the demerger. [4]
- SCL’s reported capital adequacy ratio for Q1 FY27 was 20.1%. [5]
Analytical implication: the demerger will increase SCL’s asset base and risk-weighted exposures by transferring the NBFC undertaking, while also bringing across the associated liabilities and whatever capital treatment applies under the Scheme. Therefore, the ratio could rise, fall, or remain broadly unchanged depending on the capital transferred, asset risk weights, provisions, and the timing of implementation. The available disclosures support the business-consolidation rationale, but do not support attributing a numerical capital-adequacy uplift to the restructuring itself.
Regarding the ₹775 crore NCD issuance, what are the specific coupon rates, tenor, and security cover details disclosed in the term sheet, and how does this cost of borrowing compare to the company's existing weighted average cost of funds (WACF) reported in the latest quarterly filing?
The Rs 775 Crores NCD issue carries a weighted-average coupon of approximately 9.07%; however, a numeric WACF for the latest quarter is not reported in the cited quarterly data, so the issuance cannot be conclusively judged as above or below the existing funding cost.
The charge covers the company’s present and future financial and non-financial assets, including investments and loan assets. Interest is payable annually; default interest is at least 2% per annum above the applicable coupon. [6]
Derived blended coupon: [(Rs 500 Crores × 9.05%) + (Rs 275 Crores × 9.10%)] / Rs 775 Crores = approximately 9.07%. [6]
Comparison with WACF: The 9.07% figure is the issue’s weighted-average nominal coupon, not necessarily its all-in cost of borrowing because issuance expenses and other fees are excluded. A direct comparison would be:
NCD coupon premium or discount = 9.07% − existing WACF
The latest quarterly data does not state the company’s WACF, so the direction and size of that spread cannot be calculated. Finance cost alone is not a valid substitute for WACF because it does not provide the average funding base or the relevant cost-of-funds definition.
| Series | Amount | Coupon | Tenor and maturity | Security terms |
|---|---|---|---|---|
| Series I | Rs 500 Crores | 9.05% p.a. | 3 years; matures 11 September 2029 | First pari-passu hypothecation charge; minimum 1.10x cover of principal and interest [6] |
| Series II | Rs 275 Crores | 9.10% p.a. | 5 years; matures 11 September 2031 | First pari-passu hypothecation charge; minimum 1.10x cover of principal and interest [6] |
What are the remaining regulatory milestones (e.g., NCLT final order, ROC filing) required to complete the demerger process, and what is the company's stated timeline for the record date and subsequent listing of the demerged entity?
The demerger is not yet complete. Based on the latest filing, the immediate steps are declaration of shareholder-voting results and submission of the Chairperson’s report to the NCLT. The filing does not provide a date for the NCLT’s final sanction order, ROC filing, record date, or any subsequent listing.
Remaining milestones
- Shareholder voting result: The results were to be declared within two working days of the 10 September 2026 meeting and filed on the company and KFintech websites and with BSE and NSE. [3]
- Chairperson’s report to NCLT: The report on the meeting result was to be submitted to the NCLT within three days of the meeting. [3]
- NCLT final sanction order: The meeting was held under the NCLT’s first-motion orders to obtain shareholder approval. A subsequent NCLT order sanctioning the Scheme would therefore remain a key completion milestone, but its expected date is not stated in the cited filing. [7]
- ROC and statutory filings: The Scheme provides that, after the NCLT vesting order, relevant intimations are to be filed with the statutory and other authorities. However, the cited disclosures do not specify the date or procedural deadline for filing the certified NCLT order with the Registrar of Companies. [2]
- Implementation actions: Following the sanction order and statutory filings, the companies would need to complete the Scheme’s implementation steps, including transfer of the relevant NBFC undertaking and related records, licences and approvals. [2]
Record date and listing timeline
The Scheme defines the Record Date as a date to be fixed by the Board of the Resulting Company, Sammaan Capital Limited, for determining the relevant holders for vesting of the demerged company’s NCDs. [2] The latest meeting filing does not state a calendar date or a target window for fixing it.
No company-stated timetable for the subsequent listing of a demerged entity is included in the cited material. Importantly, the Scheme identifies Sammaan Capital Limited as the Resulting Company receiving the NBFC business; the available disclosure does not establish a separate new listing date or a target listing window for Sammaan Finserve or another demerged entity. [7]
Bottom line: The process remains conditional on voting results, the Chairperson’s report, NCLT sanction and consequent statutory filings. The record date and any post-demerger listing timeline remain unspecified in the latest cited disclosures.
Sources
- [1]Sammaan Capital shareholders approve NBFC demerger scheme with 99.97% support — Scanx, 2026-09-10T00:00:00
- [2]SCHEME OF ARRANGEMENT — Sammaancapital, 2026-04-01T00:00:00
- [3]Shareholder Meeting Proceedings for Sammaan Capital Demerger Approval — 2026-09-10T15:44:33, p.2
- [4]“Sammaan Capital Limited Q4 and FY '26 Earnings Conference Call” May 20, 2026 — Sammaancapital, 2026-05-23T00:00:00
- [5]Sammaan Capital Ltd (BOM:535789) (Q1 2027) Earnings ... — Finance, 2026-09-11T16:08:15.661506
- [6]Sammaan Capital allots ₹775 crore secured NCDs via private placement — Scanx, 2026-09-11T00:00:00
- [7]Shareholder Meeting Proceedings for Sammaan Capital Demerger Approval — 2026-09-10T15:44:33, p.1
Keep digging